Read next
Biotech Sector Pivots to AI-Driven Platform Therapeutics for Pipeline Expansion
Pharmaceutical majors acquire platform technologies to accelerate early-stage drug discovery and reduce clinical failure rates.
Telehealth Integration Reaches Plateau Amid Reimbursement Shifts
Virtual care utilization has stabilized at a fraction of peak pandemic levels as insurers re-evaluate reimbursement rates and…
Biotech Manufacturing Constraints Limit GLP-1 Market Expansion
Injectable drug demand outpaces contract manufacturing fill-finish capacity, spurring facility acquisitions.
Smartphone Tendonitis – What Do You Need to Know About?
Many of us think that smartphone tendonitis is an imaginary condition but, we must tell you that it…
Clinical Trials Highlight Broad Cardiovascular Benefits of GLP-1 Therapeutics
Expanding clinical datasets demonstrate that GLP-1 receptor agonists reduce major adverse cardiovascular events independently of weight loss metrics.
GLP-1 Supply Disruption Analysis Points to Active Ingredient Bottlenecks
Pharmaceutical manufacturers struggle to expand output of peptide active ingredients, threatening global distribution schedules for weight-management therapeutics.